Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview EJ Her, A Haworth, P Rowshanfarzad, MA Ebert Cancers 12 (4), 854, 2020 | 9 | 2020 |
Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI EJ Her, A Haworth, HM Reynolds, Y Sun, A Kennedy, V Panettieri, ... Radiation Oncology 15 (1), 1-13, 2020 | 8 | 2020 |
Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy EJ Her, HM Reynolds, C Mears, S Williams, C Moorehouse, JL Millar, ... Physics in Medicine & Biology 63 (13), 135011, 2018 | 3 | 2018 |
Standard versus hypofractionated intensity-modulated radiotherapy for prostate cancer: assessing the impact on dose modulation and normal tissue effects when using patient … EJ Her, MA Ebert, AM Kennedy, HM Reynolds, Y Sun, S Williams, ... Physics in Medicine & Biology, 2020 | 2 | 2020 |
Hypofractionated Intensity-Modulated Radiotherapy (IMRT) for Prostate Cancer Using Patient-Specific Cancer Biology E Her, A Haworth, A Kennedy, H Reynolds, Y Sun, M Bangert, S Williams, ... MEDICAL PHYSICS 45 (6), E507-E507, 2018 | | 2018 |
Biologically optimized IMRT plans for prostate cancer using population-based tumour biology EJ Her, MA Ebert, HM Reynolds, A Kennedy, A Haworth Radiotherapy and Oncology 123, S843-S844, 2017 | | 2017 |
Analysis of magnetic resonance spectral data for the prediction of prostate cancer treatment response EJ Her | | |